Drug Type Fusion protein |
Synonyms RSLV 145, RSLV145 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hidradenitis Suppurativa | Preclinical | US | 01 Feb 2025 | |
Lupus Nephritis | Preclinical | US | 28 Feb 2024 |